Evaluating the Antifungal Activity of Nano-curcumin against Candida Species Isolated from Otomycosis Patients.

This article discusses a study that evaluated the antifungal activity of nano-curcumin against Candida species, which cause otomycosis, a fungal infection of the ear. The study found that nano-curcumin showed some antifungal activity against Candida, but it was less effective than commonly used antifungal drugs. However, due to its safety profile, nano-curcumin could be considered as a potential treatment option for otomycosis with further research. The study was conducted in Iran and approved by the Research Ethics Committee of Babol University of Medical Sciences. [Extracted from the article]

Copyright of Journal of Advanced Biomedical Sciences is the property of Fasa University of Medical Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)